Alpha Teknova tumbles on deep-discounted $40 mln stock sale

By Reuters News

** Molecular biology reagents maker Alpha Teknova's TKNO.O shares tumble 30.7% before the bell to $5.12, a more than two-month low, after $40 mln follow-on priced

** TKNO late Tues announced 8 mln shares at $5, a 32.3% discount to last sale

** TD Cowen and William Blair joint bookrunners

** Co intends to use net offering for general corporate purposes, including potential repayment of debt, and may use a portion for acquisitions or investments in other businesses, products, and technologies

** Hollister, California-based firm has ~53.7 mln shares outstanding

** Through Tues, TKNO stock had surged ~94% YTD

** 7 of 8 analysts rate the stock "strong buy" or "buy", 1 "hold"; median PT $9.50, per LSEG

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk